Sign in
Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Annual Meeting Talks
2021
The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During the COVID-19 Pandemic
Sunir J. Garg, MD, FACS, FASRS
Patient Comfort and Antimicrobial Efficacy of Aqueous Chlorhexidine Versus Povidone Iodine as Disinfectant Prior to Bilateral Intravitreal Injections
Ferhina S Ali, MD, MPH
Updates from the Field
2019
Category: Risk Management